Wendy Stock to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Wendy Stock has written about Drug Evaluation, Preclinical.
Connection Strength
0.206
-
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. Blood Adv. 2019 01 08; 3(1):96-104.
Score: 0.160
-
New Approaches to Treating Challenging Subtypes of ALL in AYA Patients. Curr Hematol Malig Rep. 2020 12; 15(6):424-435.
Score: 0.046